Noreen Parsons
Senior Strategic Advisor Commercial Strategy
Noreen is an experienced industry executive with 25+ years of leading teams in global , regional and local commercial strategy and transformation, pricing and market access, new product planning , portfolio strategy, go -to -market/launch excellence & life cycle management. She has also led an access to medicines consulting business and held board positions for joint ventures in the biosimilar space.
Noreen believes in innovative, dynamic , collaborative and expertise- based approach to optimizing opportunities and problem-solving. She has worked across multiple therapy areas throughout her career and most recently has enjoyed global leadership roles in oncology and immunology.
Her academic qualifications span science and business with a BSc in Pharmacy (Portsmouth) and a MSc in Marketing ( Manchester) and an MBA (Lancaster).
Latest news
Clarivate Announces the India Research Excellence – Citation Awards 2025
The 10th Edition to Honor Researchers and Institutions for Pioneering Contributions to Research London, U.K. September 19, 2025. Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced…
BioWorld by Clarivate Celebrates 35 Years of Trusted Biopharma and Medtech Journalism
Award-winning independent news and analysis continue to guide life sciences leaders through rapid scientific and market change London, U.K. — September 18, 2025 — BioWorld, published by Clarivate Plc (NYSE:CLVT),…